NASDAQ:GHDX - Genomic Health Price Target & Analyst Ratings

$55.97
-0.22 (-0.39 %)
(As of 07/21/2019 01:14 AM ET)
Today's Range
$55.63
Now: $55.97
$56.47
50-Day Range
$51.14
MA: $55.15
$60.42
52-Week Range
$50.77
Now: $55.97
$92.18
Volume219,929 shs
Average Volume445,565 shs
Market Capitalization$2.07 billion
P/E Ratio53.30
Dividend YieldN/A
Beta1.07

Analyst Ratings

Genomic Health (NASDAQ:GHDX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Genomic Health in the last 12 months. Their average twelve-month price target is $63.50, suggesting that the stock has a possible upside of 13.45%. The high price target for GHDX is $85.00 and the low price target for GHDX is $50.00. There are currently 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.302.30
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
1 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
1 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $63.50$63.50$61.7143$56.4286
Price Target Upside: 13.45% upside15.25% upside22.62% downside9.31% downside

Genomic Health (NASDAQ:GHDX) Consensus Price Target History

Genomic Health (NASDAQ:GHDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/20/2019Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$72.00LowView Rating Details
6/19/2019Needham & Company LLCSet Price TargetBuy$69.00MediumView Rating Details
5/30/2019Deutsche BankLower Price TargetHold$80.00 ➝ $55.00LowView Rating Details
5/8/2019Canaccord GenuityReiterated RatingBuy$95.00 ➝ $85.00HighView Rating Details
12/19/2018CIBCInitiated CoverageMarket Perform ➝ Market PerformMediumView Rating Details
12/19/2018OppenheimerInitiated CoverageMarket PerformHighView Rating Details
10/23/2018Raymond JamesInitiated CoverageMkt Perform ➝ Market PerformLowView Rating Details
8/6/2018CowenReiterated RatingHold$50.00LowView Rating Details
8/3/2018Jefferies Financial GroupReiterated RatingHold$50.00HighView Rating Details
6/13/2018LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral$33.00LowView Rating Details
1/8/2018BarclaysReiterated RatingSell$28.00MediumView Rating Details
12/20/2017William BlairDowngradeOutperform ➝ Market PerformLowView Rating Details
12/13/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$25.00HighView Rating Details
(Data available from 7/21/2017 forward)
This page was last updated on 7/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel